Clinical Trial 13279

Boston, MA 02115


Study Summary:

Do you have rheumatoid arthritis?
Have you already used medicines and they did not work?

We are conducting a study examining the effectiveness of secukinumab, an investigational drug, in rheumatoid arthritis for those who still have symptoms after other treatments.


Qualified Participants Must:

• Be at least 18 years of age
• Have the presence of rheumatoid arthritis with active disease
• Have taken at least one of the following Enbrel® (etanercept), HUMIRA® (adalimumab), Remicade® (infliximab), Cimzia® (certolizumab), or Simponi® (goblimumab) for at least 3 months and experienced an inadequate response
• Plan on remaining in the Boston area for the next year
• Be willing to complete questionnaires and undergo: Physical exam with pain assessment and disease activity assessment and blood and urine collections


Qualified Participants May Receive:

There is no charge for any research evaluations, physician visits or procedures.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.